{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260817124577/en/United-Therapeutics-Corporation-Announces-Full-Enrollment-of-the-TETON-PPF-Study-of-Inhaled-Treprostinil-for-the-Treatment-of-Progressive-Pulmonary-Fibrosis", "message": "News view counter 886437 successfully enlarged"}